Skip to main content

Advertisement

Fig. 1 | Clinical Epigenetics

Fig. 1

From: PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease

Fig. 1

PLD3 expression is decreased in human hippocampus in Alzheimer’s disease (AD). a The graph shows a significant 1.67-fold decrease in PLD3 mRNA levels in AD hippocampal samples compared to control hippocampal samples. b PLD3 mRNA expression decreased across AD stages, as shown when PLD3 mRNA expression levels are sorted by Braak and Braak stages. Bars represent percentage of PLD3 mRNA expression relative to ACTB housekeeping gene expression. Vertical lines represent the standard error of the mean. *p value < 0.05; ***p value < 0.001. c Western blot analysis of PLD3 shows a mild protein expression decrease in AD. Human hippocampus samples from controls or AD patients were loaded as labeled on top of lanes. GADPH expression is shown as reference control. The bar chart represents the quantitative measurement of the PLD3 protein relative to GAPDH protein expression

Back to article page